13G Filing: Longboard Capital Advisors, Llc and Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY)

Page 3 of 5 – SEC Filing

Item 1.
(a) Name of Issuer
Imprimis Pharmaceuticals, Inc.
(b) Address of Issuer’s Principal Executive
Offices

12264 El Camino Real, Suite 350

San Diego, CA 92130
Item 2.
(a) Name of Person Filing
Longboard Capital Advisors, LLC
Brett Conrad
(b) Address of Principal Business Office or, if None, Residence

1312 Cedar St. Santa
Monica, California 90405

(c) Citizenship
Longboard Capital Advisors, LLC – Delaware
Brett Conrad – USA
(d) Title and Class of Securities
Common Stock, $0.001 par value
(e) CUSIP No.

45323A201

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [_] Broker or dealer registered under Section 15 of the Act;
(b) [_] Bank as defined in Section 3(a)(6) of the Act;
(c) [_] Insurance company as defined in Section 3(a)(19) of the Act;
(d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;
(e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
(j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
(k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

 

Page 3 of 5

Follow Harrow Inc. (NASDAQ:HROW)